value of drugs

ACSH friend, Dr. Robert Popovian, the Senior Director of Healthcare, Science and Economic Advocacy and U.S. Government Relations at Pfizer, is arguably one of the world s premier experts in all aspects of the industry, from early stage discovery to development, as well as innovation, economics, and government policy.
When a drug or medical device becomes available in the marketplace, few if any experts (including doctors) or individual patients question its price. In her article in the NYTimes,